ORG Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$73.5K Buy
1,363
+451
+49% +$21.7K 0.01% 504
2025
Q3
$41.2K Sell
912
-15
-2% -$701 0.01% 629
2025
Q2
$44.1K Buy
927
+196
+27% +$9.62K 0.01% 572
2025
Q1
$43.6K Sell
731
-204
-22% -$11.9K 0.01% 518
2024
Q4
$53K Sell
935
-46
-5% -$2.57K 0.01% 542
2024
Q3
$50.9K Sell
981
-10,483
-91% -$492K 0.01% 513
2024
Q2
$473K Buy
11,464
+10,170
+786% +$455K 0.06% 254
2024
Q1
$68.6K Sell
1,294
-2,688
-68% -$137K 0.13% 110
2023
Q4
$204K Sell
3,982
-4,420
-53% -$232K 0.03% 290
2023
Q3
$488K Buy
8,402
+4,483
+114% +$275K 0.14% 165
2023
Q2
$252K Buy
+3,919
New +$263K 0.04% 326

Other funds holding BMY

ORG Partners's BMY Position: Q4 2025 in Review

ORG Partners increased its Bristol-Myers Squibb (BMY) stake by 49% in Q4 2025, buying an estimated $21.7K and bringing the position to 1,363 shares worth $73.5K. The position accounts for 0.01% of the portfolio, ranked #504.

ORG Partners first reported a position in BMY in Q2 2023 and has held it in 11 quarters since. The position peaked at $488K in Q3 2023. 2,455 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • ORG Partners held 1,363 shares of Bristol-Myers Squibb worth $73.5K as of Q4 2025.
  • ORG Partners bought 451 Bristol-Myers Squibb shares in Q4 2025, an estimated $21.7K.
  • Bristol-Myers Squibb made up 0.01% of ORG Partners's portfolio in Q4 2025, its #504 holding.
  • ORG Partners first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 11 quarters since.
  • ORG Partners's Bristol-Myers Squibb position peaked at $488K in Q3 2023.
  • 2,455 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.